Patient and Care Partner Experiences Living With Multiple Myeloma PACE-MM

What's the purpose of this trial?

This study aims to identify the factors, for example, age, race, sex, education, household income, clinical or other geriatric conditions such as depression, anxiety, or lack of social support that can predict those most likely to experience changes in physical and cognitive function and quality of life. Furthermore, patients and care partners experienced challenges, because of multiple myeloma and its associated treatments, will be studied using semi-structured interviews.

This trial is currently open and accepting patients.

What will happen during the trial?

You may be able to join this trial if you:

The following criteria is a partial list of reasons why patients may be eligible to participate in this clinical trial. Further evaluation with a medical professional is required.

Inclusion Criteria:

Patients must meet the following inclusion criteria to participate in this study:

  • Aged ≥55
  • New myeloma diagnosis as defined by the International Myeloma Working Group, does not have another non-myeloma plasma cell disorder such as POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes) or amyloidosis.
  • Starting systemic treatment.
  • Able to understand and speak in English.
  • Able to provide informed consent to participate.

Care Partners must meet the following inclusion criteria to participate in this study

  • Aged ≥18.
  • Able to understand and speak in English.
  • Able to provide informed consent to participate.
  • Be a care partner for a patient with multiple myeloma and is also enrolled in the assessment portion of this study.
  • Willing and able to participate in semi-structured interviews.

Exclusion Criteria:

  • All participants meeting any of the following exclusion criteria at enrollment will be excluded from the study: Inability to read and speak English.
  • Dementia altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent.

Additional Trial Information

Observational Trial

Enrollment: 70 patients (estimated)

View More
Need Help?

Interested in joining or learning more about this trial?

(888) 828-2206

Trial Locations

All Trial Locations

View all clinical trial locations sorted by state.

North Carolina

UNC Lineberger Comprehensive Cancer Center University of North Carolina

Chapel Hill, NC

Open and Accepting
Interested in this trial?
  • Call us today 😀 keyboard_arrow_right

    We know how difficult and confusing this process can be. If you are interested in this clinical trial or have questions, you can call us at any time. You can also send us a direct message with questions.

    (888) 828-2206
  • Add this trial to your favorites keyboard_arrow_right

    If you are interested in keeping an eye on this trial, you can add it to your list of favorite trials. We'll send you alerts when this trial is updated.

  • Talk to your doctor keyboard_arrow_right

    You can print an overview of this trial to take in to your next appointment. Your doctor can help you understand if this trial may be right for you.

Still need help? Send us a message